v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Preferred Stock
Common Stock
Capital Surplus
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2024   16,750          
Beginning balance at Dec. 31, 2024 $ 9,111 $ 426 $ 328 $ 4,808 $ 4,382 $ (1,128) [1] $ 295
Beginning balance (in shares) at Dec. 31, 2024     524,280,412        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 222       218   4
Other comprehensive income (loss) 145         145 [1]  
Cash dividends declared:              
Preferred stock (5)       (5)    
Common stock (78)       (78)    
Common stock repurchased (in shares) [2]     (17,657,334)        
Common stock repurchased [2] (365)   $ (11) (354)      
Excise tax on common stock repurchased (3)     (3)      
Common stock issued for:              
Stock options exercised and restricted stock awards (in shares)     692,106        
Stock options exercised and restricted stock awards 3     3      
Stock-based compensation expense 18     18      
Dividends declared - noncontrolling interest of subsidiary preferred stock (4)           (4)
Ending balance (in shares) at Mar. 31, 2025   16,750          
Ending balance at Mar. 31, 2025 9,044 $ 426 $ 317 4,472 4,517 (983) [1] 295
Ending balance (in shares) at Mar. 31, 2025     507,315,184        
Beginning balance (in shares) at Dec. 31, 2024   16,750          
Beginning balance at Dec. 31, 2024 9,111 $ 426 $ 328 4,808 4,382 (1,128) [1] 295
Beginning balance (in shares) at Dec. 31, 2024     524,280,412        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 467            
Other comprehensive income (loss) 216         216  
Ending balance (in shares) at Jun. 30, 2025   16,750          
Ending balance at Jun. 30, 2025 9,257 $ 426 $ 318 4,459 4,671 (912) [1] 295
Ending balance (in shares) at Jun. 30, 2025     508,835,780        
Beginning balance (in shares) at Mar. 31, 2025   16,750          
Beginning balance at Mar. 31, 2025 9,044 $ 426 $ 317 4,472 4,517 (983) [1] 295
Beginning balance (in shares) at Mar. 31, 2025     507,315,184        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 245       241   4
Other comprehensive income (loss) 71         71 [1]  
Cash dividends declared:              
Preferred stock (8)       (8)    
Common stock (79)       (79)    
Common stock repurchased (in shares) [2]     (1,455,166)        
Common stock repurchased [2] (27)   $ (1) (26)      
Common stock issued for:              
Stock options exercised and restricted stock awards (in shares)     2,975,762        
Stock-based compensation expense 15   $ 2 13      
Dividends declared - noncontrolling interest of subsidiary preferred stock (4)           (4)
Ending balance (in shares) at Jun. 30, 2025   16,750          
Ending balance at Jun. 30, 2025 9,257 $ 426 $ 318 4,459 4,671 (912) [1] 295
Ending balance (in shares) at Jun. 30, 2025     508,835,780        
Beginning balance (in shares) at Dec. 31, 2025   8,750          
Beginning balance at Dec. 31, 2025 9,142 $ 349 $ 303 3,974 5,031 (810) [3] 295
Beginning balance (in shares) at Dec. 31, 2025     484,825,395        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 266       262   4
Other comprehensive income (loss) (22)         (22) [3]  
Cash dividends declared:              
Preferred stock (5)       (5)    
Common stock (83)       (83)    
Preferred stock issuance (in shares)   4,000          
Preferred stock issuance 392 $ 392          
Common stock repurchased (in shares) [4]     (9,578,588)        
Common stock repurchased [4] (235)   $ (6) (229)      
Excise tax on common stock repurchased (2)     (2)      
Common stock issued for:              
Stock options exercised and restricted stock awards (in shares)     475,425        
Stock options exercised and restricted stock awards 3     3      
Stock-based compensation expense 13     13      
Dividends declared - noncontrolling interest of subsidiary preferred stock (4)           (4)
Ending balance (in shares) at Mar. 31, 2026   12,750          
Ending balance at Mar. 31, 2026 9,465 $ 741 $ 297 3,759 5,205 (832) [3] 295
Ending balance (in shares) at Mar. 31, 2026     475,722,232        
Beginning balance (in shares) at Dec. 31, 2025   8,750          
Beginning balance at Dec. 31, 2025 9,142 $ 349 $ 303 3,974 5,031 (810) [3] 295
Beginning balance (in shares) at Dec. 31, 2025     484,825,395        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 541            
Other comprehensive income (loss) $ (36)         (36)  
Ending balance (in shares) at Jun. 30, 2026 7,000 7,000          
Ending balance at Jun. 30, 2026 $ 9,463 $ 682 $ 296 3,653 5,383 (846) [3] 295
Ending balance (in shares) at Jun. 30, 2026     473,919,939        
Beginning balance (in shares) at Mar. 31, 2026   12,750          
Beginning balance at Mar. 31, 2026 9,465 $ 741 $ 297 3,759 5,205 (832) [3] 295
Beginning balance (in shares) at Mar. 31, 2026     475,722,232        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 274       270   4
Other comprehensive income (loss) (14)         (14) [3]  
Cash dividends declared:              
Preferred stock (13)       (13)    
Common stock (82)       (82)    
Series C preferred stock redemption (in shares)   (5,750)          
Series C preferred stock redemption (57) $ (59)     2    
Refund of excise tax on Series D preferred stock redemption 1       1    
Common stock repurchased (in shares) [4]     (4,954,557)        
Common stock repurchased [4] (121)   $ (3) (118)      
Excise tax on common stock repurchased (1)     (1)      
Common stock issued for:              
Stock options exercised and restricted stock awards (in shares)     3,152,264        
Stock options exercised and restricted stock awards 1     1      
Stock-based compensation expense 14   $ 2 12      
Dividends declared - noncontrolling interest of subsidiary preferred stock $ (4)           (4)
Ending balance (in shares) at Jun. 30, 2026 7,000 7,000          
Ending balance at Jun. 30, 2026 $ 9,463 $ 682 $ 296 $ 3,653 $ 5,383 $ (846) [3] $ 295
Ending balance (in shares) at Jun. 30, 2026     473,919,939        
[1] Due to the nature of the preferred stock issued by FHN and its subsidiaries, all components of other comprehensive income (loss) have been attributed solely to FHN as the controlling interest holder.
[2] Includes $360 million and $9 million repurchased during first and second quarter, respectively, under FHN's general purchase program.
[3] Due to the nature of the preferred stock issued by FHN and its subsidiaries, all components of other comprehensive income (loss) have been attributed solely to FHN as the controlling interest holder.
[4] Includes $233 million and $100 million repurchased during first and second quarter, respectively, under FHN's general purchase program.